Charles River Laboratories International (CRL) Deferred Taxes (2009 - 2025)

Charles River Laboratories International (CRL) has reported Deferred Taxes for 17 consecutive years, with -$60.2 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Deferred Taxes fell 45.2% year-over-year to -$60.2 million; the TTM figure through Dec 2025 stood at -$75.3 million (down 11.66% YoY), while the FY2025 annual figure was -$75.3 million, down 11.66% from the prior year.
• Deferred Taxes came in at -$60.2 million for Q4 2025 at Charles River Laboratories International, down from $25.9 million in the prior quarter.
• The five-year high for Deferred Taxes was $25.9 million in Q3 2025, with the low at -$60.2 million in Q4 2025.
• Average Deferred Taxes over 5 years is -$12.7 million, with a median of -$11.6 million recorded in 2022.
• Across the five-year window, Deferred Taxes soared 477.25% in 2021 and plunged 1829.18% in 2025, its largest moves.
• Year by year, Deferred Taxes stood at -$10.2 million in 2021, then increased by 6.71% to -$9.6 million in 2022, then tumbled by 136.92% to -$22.7 million in 2023, then tumbled by 82.94% to -$41.4 million in 2024, then slumped by 45.2% to -$60.2 million in 2025.
• According to Business Quant data, Deferred Taxes over the past three periods registered -$60.2 million, $25.9 million, and -$22.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.